blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3601325

EP3601325 - NEW TAU SPECIES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.05.2024
Database last updated on 31.08.2024
FormerThe patent has been granted
Status updated on  16.06.2023
FormerGrant of patent is intended
Status updated on  27.02.2023
FormerExamination is in progress
Status updated on  24.07.2020
FormerRequest for examination was made
Status updated on  03.01.2020
FormerThe international publication has been made
Status updated on  06.10.2018
Formerunknown
Status updated on  19.04.2018
Most recent event   Tooltip02.08.2024Lapse of the patent in a contracting state
New state(s): SI
published on 04.09.2024 [2024/36]
Applicant(s)For all designated states
INSERM (Institut National de la Santé et de la Recherche Médicale)
101, rue de Tolbiac
75013 Paris / FR
For all designated states
Université de Lille
42, rue Paul Duez
59800 Lille / FR
For all designated states
Centre Hospitalier Regional Universitaire de Lille
2, avenue Oscar Lambret
59000 Lille / FR
For all designated states
Centre National de la Recherche Scientifique (CNRS)
3, rue Michel Ange
75016 Paris / FR
For all designated states
Ecole Supérieure de Physique et de Chimie Industrielles de la Ville de Paris
10, rue Vauquelin
75005 Paris / FR
[2020/06]
Inventor(s)01 / BUEE, Luc
UMR-S U1172
Faculté de Médecine Henri Warembourg
1 Place de Verdun
59045 Lille Cedex / FR
02 / HAMDANE, Malika
UMR-S U1172
Faculté de Médecine Henri Warembourg
1 Place de Verdun
59045 Lille Cedex / FR
03 / BLUM, David
UMR-S U1172
Faculté de Médecine Henri Warembourg
1 Place de Verdun
59045 Lille Cedex / FR
04 / DERISBOURG, Maxime
UMR-S U1172
Faculté de Médecine Henri Warembourg
1 Place de Verdun
59045 Lille Cedex / FR
05 / LEGHAY, Coline
UMR-S U1172
Faculté de Médecine Henri Warembourg
1 Place de Verdun
59045 Lille Cedex / FR
06 / CHIAPPETTA, Giovanni
USR 3149 ESPCI
CNRS
10 Rue Vauquelin
75231 Paris Cedex 5 / FR
07 / VINH, Joëlle
USR 3149 ESPCI
CNRS
10 Rue Vauquelin
75231 Paris Cedex 5 / FR
08 / VERDIER, Yann
USR 3149 ESPCI
CNRS
10 Rue Vauquelin
75231 Paris Cedex 5 / FR
 [2020/06]
Representative(s)Inserm Transfert
PariSanté Campus
10 rue d'Oradour-sur-Glane
75015 Paris / FR
[2023/29]
Former [2020/06]Inserm Transfert
7, rue Watt
75013 Paris / FR
Application number, filing date18715588.227.03.2018
[2020/06]
WO2018EP57772
Priority number, dateEP2017030535528.03.2017         Original published format: EP 17305355
[2020/06]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018178078
Date:04.10.2018
Language:EN
[2018/40]
Type: A1 Application with search report 
No.:EP3601325
Date:05.02.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 04.10.2018 takes the place of the publication of the European patent application.
[2020/06]
Type: B1 Patent specification 
No.:EP3601325
Date:19.07.2023
Language:EN
[2023/29]
Search report(s)International search report - published on:EP04.10.2018
ClassificationIPC:C07K14/47, G01N33/53, G01N33/68
[2020/06]
CPC:
C07K14/471 (EP); C07K14/4711 (EP,US); C07K16/18 (US);
G01N33/6896 (EP,US); G01N2800/2821 (EP,US); G01N2800/7047 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/06]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:NEUE ARTEN VON TAU[2023/09]
English:NEW TAU SPECIES[2020/06]
French:NOUVELLES ESPECES DE TAU[2023/09]
Former [2020/06]NEUE TAU-SPEZIES
Former [2020/06]NOUVELLE ESPÈCE TAU
Entry into regional phase27.09.2019National basic fee paid 
27.09.2019Designation fee(s) paid 
27.09.2019Examination fee paid 
Examination procedure27.09.2019Examination requested  [2020/06]
27.09.2019Date on which the examining division has become responsible
19.05.2020Amendment by applicant (claims and/or description)
24.07.2020Despatch of a communication from the examining division (Time limit: M06)
18.01.2021Reply to a communication from the examining division
04.10.2021Despatch of a communication from the examining division (Time limit: M02)
06.12.2021Reply to a communication from the examining division
28.02.2023Communication of intention to grant the patent
07.06.2023Fee for grant paid
07.06.2023Fee for publishing/printing paid
07.06.2023Receipt of the translation of the claim(s)
Opposition(s)22.04.2024No opposition filed within time limit [2024/26]
Fees paidRenewal fee
20.03.2020Renewal fee patent year 03
23.03.2021Renewal fee patent year 04
23.03.2022Renewal fee patent year 05
22.03.2023Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT19.07.2023
CZ19.07.2023
DK19.07.2023
EE19.07.2023
ES19.07.2023
FI19.07.2023
HR19.07.2023
LT19.07.2023
LV19.07.2023
NL19.07.2023
PL19.07.2023
RO19.07.2023
RS19.07.2023
SE19.07.2023
SI19.07.2023
SK19.07.2023
SM19.07.2023
NO19.10.2023
GR20.10.2023
IS19.11.2023
PT20.11.2023
[2024/36]
Former [2024/23]AT19.07.2023
CZ19.07.2023
DK19.07.2023
EE19.07.2023
ES19.07.2023
FI19.07.2023
HR19.07.2023
LT19.07.2023
LV19.07.2023
NL19.07.2023
PL19.07.2023
RO19.07.2023
RS19.07.2023
SE19.07.2023
SK19.07.2023
SM19.07.2023
NO19.10.2023
GR20.10.2023
IS19.11.2023
PT20.11.2023
Former [2024/22]AT19.07.2023
CZ19.07.2023
DK19.07.2023
FI19.07.2023
HR19.07.2023
LT19.07.2023
LV19.07.2023
NL19.07.2023
PL19.07.2023
RO19.07.2023
RS19.07.2023
SE19.07.2023
SM19.07.2023
NO19.10.2023
GR20.10.2023
IS19.11.2023
PT20.11.2023
Former [2024/20]AT19.07.2023
FI19.07.2023
HR19.07.2023
LT19.07.2023
LV19.07.2023
NL19.07.2023
PL19.07.2023
RS19.07.2023
SE19.07.2023
SM19.07.2023
NO19.10.2023
GR20.10.2023
IS19.11.2023
PT20.11.2023
Former [2024/10]AT19.07.2023
FI19.07.2023
HR19.07.2023
LT19.07.2023
LV19.07.2023
NL19.07.2023
PL19.07.2023
RS19.07.2023
SE19.07.2023
NO19.10.2023
GR20.10.2023
IS19.11.2023
PT20.11.2023
Former [2024/09]AT19.07.2023
FI19.07.2023
LT19.07.2023
NL19.07.2023
SE19.07.2023
NO19.10.2023
GR20.10.2023
IS19.11.2023
Former [2024/08]LT19.07.2023
NL19.07.2023
NO19.10.2023
GR20.10.2023
Former [2024/05]NL19.07.2023
Cited inInternational search[A]WO2011056300  (DAVID GLADSTONE INST [US], et al) [A] 1-14 * paragraph [[0006]] - paragraph [[0016]]; figures 1-10 * * Detailed description. Examples; paragraph [[0029]] - paragraph [[0046]]; table 1 *;
 [X]  - MAXIME DERISBOURG ET AL, "Role of the Tau N-terminal region in microtubule stabilization revealed by new endogenous truncated forms", SCIENTIFIC REPORTS, (20150514), vol. 5, no. 1, doi:10.1038/srep09659, XP055395382 [X] 1-14 * abstract * * Introduction * * Results, page 2, 1st column Paragraph 1. N-terminal truncates of Tau. * * Discussion, pages 4-6.;; figures 1, 2; table 1 *

DOI:   http://dx.doi.org/10.1038/srep09659
 [A]  - ROBERT A RISSMAN ET AL, "Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology", JOURNAL OF CLINICAL INVESTIGATION, AMERICAN SOCIETY FOR CLINICAL INVESTIGATION, US, (20040701), vol. 114, no. 1, doi:10.1172/JCI200420640, ISSN 0021-9738, pages 121 - 130, XP002734348 [A] 1-14 * abstract * * Introduction, p. 121 * * Discussion, Figure 11 *

DOI:   http://dx.doi.org/10.1172/JCI200420640
 [A]  - TODD J. COHEN ET AL, "The acetylation of tau inhibits its function and promotes pathological tau aggregation", NATURE COMMUNICATIONS, (20110322), vol. 2, doi:10.1038/ncomms1255, page 252, XP055397255 [A] 1-14 * abstract * * Introduction *

DOI:   http://dx.doi.org/10.1038/ncomms1255
 [A]  - HANNA TRZECIAKIEWICZ ET AL, "A Dual Pathogenic Mechanism Links Tau Acetylation to Sporadic Tauopathy", SCIENTIFIC REPORTS, (20170313), vol. 7, doi:10.1038/srep44102, page 44102, XP055397271 [A] 1-14 * abstract * * Introduction *

DOI:   http://dx.doi.org/10.1038/srep44102
 [A]  - DAVID J. IRWIN ET AL, "Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies", BRAIN., GB, (20120224), vol. 135, no. 3, doi:10.1093/brain/aws013, ISSN 0006-8950, pages 807 - 818, XP055397395 [A] 1-14 * abstract * * Introduction *

DOI:   http://dx.doi.org/10.1093/brain/aws013
 [A]  - MAR PEREZ ET AL, "Tau - an inhibitor of deacetylase HDAC6 function", JOURNAL OF NEUROCHEMISTRY, (20090601), vol. 109, no. 6, doi:10.1111/j.1471-4159.2009.06102.x, ISSN 0022-3042, pages 1756 - 1766, XP055044600 [A] 1-14 * abstract * * Introduction *

DOI:   http://dx.doi.org/10.1111/j.1471-4159.2009.06102.x
 [A]  - SANG-WON MIN ET AL, "Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits", NATURE MEDICINE, (20150921), vol. 21, no. 10, doi:10.1038/nm.3951, ISSN 1078-8956, pages 1154 - 1162, XP055397314 [A] 1-14 * Abstract and Introduction *

DOI:   http://dx.doi.org/10.1038/nm.3951
by applicantEP0368684
 US2004161738
 WO2006003388
 WO2006030220
    - "Uniprot", Database accession no. P10636-8
    - REYNOLDS, C. H. et al., J. Neurochem., (19970000), vol. 69, pages 191 - 198
    - "Uniprot", Database accession no. P10636-2
    - "Uniprot", Database accession no. P10636-4
    - "Uniprot", Database accession no. P10636-6
    - "Uniprot", Database accession no. P10636-5
    - "Uniprot", Database accession no. P10636-7
    - "Uniprot", Database accession no. P10636-9
    - KENT S.B.H., Chem. Soc. Rev., (20090000), vol. 38, pages 338 - 351
    - BRADLEY L. et al., Annu Rev Biophys Biomol Struct., (20050000), vol. 34, pages 91 - 118
    - R. B. MERRIFIELD, "Solid-phase peptide synthesis", Advances in enzymology and related areas of molecular biology, (19690000), vol. 32, pages 221 - 96, XP002957003
    - R. B. MERRIFIELD, "The synthesis of biologically active peptides and proteins", JAMA, (19690000), vol. 210, no. 7, pages 1247 - 54
    - Ausubel et al., Current Protocols in Molecular Biology, John Wiley & sons, Inc., (19940000), vol. 1
    - HOLLIGER et al., Nature Biotechnology, (20050000), vol. 23, no. 9, pages 1126 - 1136
    - WARD et al., Nature, (19891012), vol. 341, no. 6242, pages 544 - 6
    - HOLT et al., Trends Biotechnol., (20030000), vol. 21, no. 11, pages 484 - 490
    - TUERK et al., Science, (19900000), vol. 249, pages 505 - 510
    - COLAS et al., Nature, (19960000), vol. 380, pages 548 - 50
    - IQBAL, K. et al., Biochimica et Biophysica Acta (BBA, (20050000), vol. 1739, pages 198 - 210
    - AKSNES H; DRAZIC A; MARIE M; ARNESEN T, "First Things First: Vital Protein Marks by N-Terminal Acetyltransferases", Trends Biochem Sci, (20160000), vol. 41, doi:doi:10.1016/j.tibs.2016.07.005, pages 746 - 60, XP029703477

DOI:   http://dx.doi.org/10.1016/j.tibs.2016.07.005
    - ARNESEN T; VAN DAMME P; POLEVODA B; HELSENS K; EVJENTH R; COLAERT N; VARHAUG JE; VANDEKERCKHOVE J; LILLEHAUG JR; SHERMAN F, "Proteomics analyses reveal the evolutionary conservation and divergence of Nterminal acetyltransferases from yeast and humans", Proc Natl Acad Sci USA, (20090000), vol. 106, pages 8157 - 62
    - BARTHELEMY NR; GABELLE A; HIRTZ C; FENAILLE F; SERGEANT N; SCHRAEN-MASCHKE S; VIALARET J; BUEE L; JUNOT C; BECHER F, "Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies", J Alzheimers Dis., (20160220), vol. 51, no. 4, pages 1033 - 43
    - BASURTO-ISLAS, G. et al., "Accumulation of aspartic acid421- and glutamic acid391-cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease", J Neuropathol Exp Neurol, (20080000), vol. 67, doi:doi:10.1097/NEN.0b013e31817275c7, pages 470 - 483, XP009181912

DOI:   http://dx.doi.org/10.1097/NEN.0b013e31817275c7
    - BRAAK H; BRAAK E, "Staging of Alzheimer's disease-related neurofibrillary changes", Neurobiol Aging., (19950000), vol. 16, doi:doi:10.1016/0197-4580(95)00021-6, pages 271 - 8, XP055219625

DOI:   http://dx.doi.org/10.1016/0197-4580(95)00021-6
    - BRAAK, H.; THAI, D. R.; GHEBREMEDHIN, E.; DEL TREDICI, K., "Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years", J Neuropathol Exp Neurol, (20110000), vol. 70, pages 960 - 969
    - BRANDT R; LEGER J; LEE G., "Interaction of tau with the neural plasma membrane mediated by tau's aminoterminal projection domain", J Cell Biol., (19950000), vol. 131, pages 1327 - 40
    - BURNOUF S; BELARBI K; TROQUIER L; DERISBOURG M; DEMEYER D; LEBOUCHER A; LAURENT C; HAMDANE M; BUEE L; BLUM D, "Hippocampal BDNF expression in a tau transgenic mouse model", Curr Alzheimer Res., (20120000), vol. 9, no. 4, pages 406 - 10
    - BURNOUF S; MARTIRE A; DERISBOURG M; LAURENT C; BELARBI K; LEBOUCHER A; FERNANDEZ-GOMEZ FJ; TROQUIER L; EDDARKAOUI S; GROSJEAN ME, "NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model", Aging Cell, (20130000), vol. 12, pages 11 - 23
    - CARMEL G; MAGER EM; BINDER LI; KURET J, "The structural basis of monoclonal antibody A1z50's selectivity for Alzheimer's disease pathology", J Biol Chem., (19960000), vol. 271, pages 32789 - 95
    - DE CALIGNON, A.; FOX, L. M.; PITSTICK, R.; CARLSON, G. A. et al., "Caspase activation precedes and leads to tangles", Nature, (20100000), vol. 464, pages 1201 - 1204
    - DELACOURTE A; DAVID JP; SERGEANT N; BUEE L; WATTEZ A; VERMERSCH P; GHOZALI F; FALLET-BIANCO C; PASQUIER F; LEBERT F, "The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease", Neurology, (19990000), vol. 52, pages 1158 - 65
    - DERISBOURG M; LEGHAY C; CHIAPPETTA G; FERNANDEZ-GOMEZ FJ; LAURENT C; DEMEYER D; CARRIER S; BUEE-SCHERRER V; BLUM D; VINH J, "Role of the Tau N-terminal region in microtubule stabilization revealed by new endogenous truncated forms", Sci Rep., (20150000), vol. 5, doi:doi:10.1038/srep09659, page 9659, XP055395382

DOI:   http://dx.doi.org/10.1038/srep09659
    - DRAZIC A; MYKLEBUST LM; REE R; ARNESEN T, "The world of protein acetylation", Biochim Biophys Acta, (20160000), vol. 1864, doi:doi:10.1016/j.bbapap.2016.06.007, pages 1372 - 401, XP029687293

DOI:   http://dx.doi.org/10.1016/j.bbapap.2016.06.007
    - DRIESSEN HP; DE JONG WW; TESSER GI; BLOEMENDAL H, "The mechanism of N-terminal acetylation of proteins", CRC Crit Rev Biochem., (19850000), vol. 18, no. 4, doi:doi:10.3109/10409238509086784, pages 281 - 325, XP008107146

DOI:   http://dx.doi.org/10.3109/10409238509086784
    - DUJARDIN S; LECOLLE K; CAILLIEREZ R; BEGARD S; ZOMMER N; LACHAUD C; CARRIER S; DUFOUR N; AUREGAN G; WINDERICKX J, "Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies", Acta Neuropathol Commun, (20140000), vol. 2, doi:doi:10.1186/2051-5960-2-14, page 14, XP021176738

DOI:   http://dx.doi.org/10.1186/2051-5960-2-14
    - DUYCKAERTS C; COLLE MA; DESSI F; PIETTE F; HAUW JJ, "Progression of Alzheimer histopathological changes", Acta Neurol Belg., (19980000), vol. 98, pages 180 - 5
    - FROST B; JACKS RL; DIAMOND MI, "Propagation of tau misfolding from the outside to the inside of a cell", J Biol Chem., (20090000), vol. 284, pages 12845 - 52
    - GAMBLIN TC; CHEN F; ZAMBRANO A; ABRAHA A; LAGALWAR S; GUILLOZET AL; LU M; FU Y; GARCIA-SIERRA F; LAPOINTE N, "Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease", Proc Natl Acad Sci USA, (20030000), vol. 100, doi:doi:10.1073/pnas.1630428100, pages 10032 - 7, XP055053496

DOI:   http://dx.doi.org/10.1073/pnas.1630428100
    - GOODE BL; FEINSTEIN SC, "Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau", J Cell Biol., (19940000), vol. 124, pages 769 - 82
    - GUO H; ALBRECHT S; BOURDEAU M; PETZKE T; BERGERON C; LEBLANC AC, "Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease", Am J Pathol., (20040000), vol. 165, pages 523 - 31
    - GUSTKE N; TRINCZEK B; BIERNAT J; MANDELKOW EM; MANDELKOW E, "Domains of tau protein and interactions with microtubules", Biochemistry, (19940000), vol. 33, pages 9511 - 22
    - HAMDANE M; SAMBO AV; DELOBEL P; BEGARD S; VIOLLEAU A; DELACOURTE A; BERTRAND P; BENAVIDES J; BUEE L, "Mitotic-like tau phosphorylation by p25-Cdk5 kinase complex", J Biol Chem., (20030000), vol. 278, pages 34026 - 34
    - HAYASHI, S. et al., "Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation", Ann. Neurol., (20020000), vol. 51, pages 525 - 530
    - HASEGAWA, M. et al., "Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain", J Biol Chem, (19920000), vol. 267, pages 17047 - 17054, XP002433876
    - HELSENS K; VAN DAMME P; DEGROEVE S; MARTENS L; ARNESEN T; VANDEKERCKHOVE J; GEVAERT K, "Bioinformatics analysis of a Saccharomyces cerevisiae N-terminal proteome provides evidence of alternative translation initiation and post-translational N-terminal acetylation", J Proteome Res., (20110000), vol. 10, pages 3578 - 89
    - HOROWITZ PM; PATTERSON KR; GUILLOZET-BONGAARTS AL; REYNOLDS MR; CARROLL CA; WEINTRAUB ST; BENNETT DA; CRYNS VL; BERRY RW; BINDER L, "Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease", J Neurosci, (20040000), vol. 24, doi:doi:10.1523/JNEUROSCI.1988-04.2004, pages 7895 - 902, XP055132970

DOI:   http://dx.doi.org/10.1523/JNEUROSCI.1988-04.2004
    - JEGANATHAN S; BERGEN M; BRUTLACH H; STEINHOFF HJ; MANDELKOW E, "Global hairpin folding of tau in solution", Biochemistry, (20060000), vol. 45, pages 2283 - 93
    - JEGANATHAN S; HASCHER A; CHINNATHAMBI S; BIERNAT J; MANDELKOW EM; MANDELKOW E, "Proline-directed pseudo-phosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of Tau and generates a pathological (MC-1) conformation", J Biol Chem., (20080000), vol. 283, pages 32066 - 76
    - JOHNSON GV; SEUBERT P; COX TM; MOTTER R; BROWN JP; GALASKO D, "The tau protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments", J Neurochem., (19970000), vol. 68, doi:doi:10.1046/j.1471-4159.1997.68010430.x, pages 430 - 3, XP008132995

DOI:   http://dx.doi.org/10.1046/j.1471-4159.1997.68010430.x
    - JUNG D; FILLIOL D; MIEHE M; RENDON A, "Interaction of brain mitochondria with microtubules reconstituted from brain tubulin and MAP2 or TAU", Cell Motil Cytoskeleton, (19930000), vol. 24, pages 245 - 55
    - KOVACECH B; NOVAK M, "Tau truncation is a productive posttranslational modification of neurofibrillary degeneration in Alzheimer's disease", Curr Alzheimer Res., (20100000), vol. 7, doi:doi:10.2174/156720510793611556, pages 708 - 16, XP008132929

DOI:   http://dx.doi.org/10.2174/156720510793611556
    - LEE G; NEWMAN ST; GARD DL; BAND H; PANCHAMOORTHY G, "Tau interacts with src-family non-receptor tyrosine kinases", J Cell Sci., (19980000), vol. 111, pages 3167 - 77, XP055072931
    - LOOMIS PA; HOWARD TH; CASTLEBERRY RP; BINDER LI, "Identification of nuclear tau isoforms in human neuroblastoma cells", Proc Natl Acad Sci USA, (19900000), vol. 87, pages 8422 - 6
    - MAGNANI E; FAN J; GASPARINI L; GOLDING M; WILLIAMS M; SCHIAVO G; GOEDERT M; AMOS LA; SPILLANTINI MG, "Interaction of tau protein with the dynactin complex", EMBO J., (20070000), vol. 26, pages 4546 - 54
    - MAILLIOT, C. et al., "Pathological tau phenotypes. The weight of mutations, polymorphisms, and differential neuronal vulnerabilities", Ann. N. Y. Acad. Sci., (20000000), vol. 920, pages 107 - 114
    - MANDELKOW EM; MANDELKOW E, "Biochemistry and cell biology of tau protein in neurofibrillary degeneration", Cold Spring Harb Perspect Med., (20120000), vol. 2, page a006247
    - MCMILLAN, P. J.; KRAEMER, B. C.; ROBINSON, L.; LEVERENZ, J. B. et al., "Truncation of tau at E391 promotes early pathologic changes in transgenic mice", J Neuropathol Exp Neurol, (20110000), vol. 70, pages 1006 - 1019
    - MUKRASCH MD; BIERNAT J; VON BERGEN M; GRIESINGER C; MANDELKOW E; ZWECKSTETTER M, "Sites of tau important for aggregation populate { beta}-structure and bind to microtubules and polyanions", J Biol Chem., (20050000), vol. 280, pages 24978 - 86
    - NOVAK M; KABAT J; WISCHIK CM, "Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament", EMBO J., (19930000), vol. 12, pages 365 - 70, XP009019837
    - PANDEY, "Hybridoma technology for production of monoclonal antibodies", Hybridoma, (20100000), vol. 1, no. 2, page 017
    - POLEVODA B; SHERMAN F, "Composition and function of the eukaryotic N-terminal acetyltransferase subunits", Biochem Biophys Res Commun., (20030000), vol. 308, doi:doi:10.1016/S0006-291X(03)01316-0, pages 1 - 11, XP004441410

DOI:   http://dx.doi.org/10.1016/S0006-291X(03)01316-0
    - POORKAJ, P. et al., "An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype", Ann. Neurol., (20020000), vol. 52, pages 511 - 516
    - RISSMAN RA; POON WW; BLURTON-JONES M; ODDO S; TORP R; VITEK MP; LAFERLA FM; ROHN TT; COTMAN CW, "Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology", J Clin Invest., (20040000), vol. 114, doi:doi:10.1172/JCI200420640, pages 121 - 30, XP002734348

DOI:   http://dx.doi.org/10.1172/JCI200420640
    - SCHINDOWSKI K; BRETTEVILLE A; LEROY K; BEGARD S; BRION JP; HAMDANE M; BUEE L, "Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits", Am J Pathol., (20060000), vol. 169, pages 599 - 616
    - SERGEANT N; BRETTEVILLE A; HAMDANE M; CAILLET-BOUDIN ML; GROGNET P; BOMBOIS S; BLUM D; DELACOURTE A; PASQUIER F; VANMECHELEN E, "Biochemistry of Tau in Alzheimer's disease and related neurological disorders", Expert Rev Proteomics, (20080000), vol. 5, pages 207 - 24
    - SULTAN A; NESSLANY F; VIOLET M; BEGARD S; LOYENS A; TALAHARI S; MANSUROGLU Z; MARZIN D; SERGEANT N; HUMEZ S, "Nuclear tau, a key player in neuronal DNA protection", J Biol Chem., (20110000), vol. 286, pages 4566 - 75
    - VAN DER JEUGD A; BLUM D; RAISON S; EDDARKAOUI S; BUEE L; D'HOOGE R, "Observations in THY-Tau22 mice that resemble behavioral and psychological signs and symptoms of dementia", Behav Brain Res., (20130000), vol. 242, doi:doi:10.1016/j.bbr.2012.12.008, pages 34 - 9, XP028969693

DOI:   http://dx.doi.org/10.1016/j.bbr.2012.12.008
    - BERGEN M; FRIEDHOFF P; BIERNAT J; HEBERLE J; MANDELKOW EM; MANDELKOW E, "Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure", Proc Natl Acad Sci USA, (20000000), vol. 97, doi:doi:10.1073/pnas.97.10.5129, pages 5129 - 34, XP000982226

DOI:   http://dx.doi.org/10.1073/pnas.97.10.5129
    - ZILKA, N. et al., "Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo", FEBS Letters, (20060000), vol. 580, doi:doi:10.1016/j.febslet.2006.05.029, pages 3582 - 3588, XP028030674

DOI:   http://dx.doi.org/10.1016/j.febslet.2006.05.029
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.